Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Decreased nervonic acid levels in erythrocyte membranes predict psychosis in help-seeking ultra-high-risk individuals.

Literature DB >> 22182937

Decreased nervonic acid levels in erythrocyte membranes predict psychosis in help-seeking ultra-high-risk individuals.

G P Amminger, M R Schäfer, C M Klier, J-M Slavik, I Holzer, M Holub, S Goldstone, T J Whitford, P D McGorry, M Berk.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2011 PMID： 22182937 DOI： 10.1038/mp.2011.167

Source DB: PubMed Journal: Mol Psychiatry ISSN： 1359-4184 Impact factor: 15.992

Keyword Cloud
Cited

× No keyword cloud information.

35 in total

Review 1. New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates--Nrf2 activators and GSK-3 inhibitors.

Authors: Michael Maes; Zdenĕk Fišar; Miguel Medina; Giovanni Scapagnini; Gabriel Nowak; Michael Berk
Journal: Inflammopharmacology Date: 2012-01-24 Impact factor: 4.473

2. Impact of hydroxyurea therapy on serum fatty acids of β-thalassemia patients.

Authors: Ayesha Iqbal; Amna Jabbar Siddiqui; Jian-Hua Huang; Saqib Hussain Ansari; Syed Ghulam Musharraf
Journal: Metabolomics Date: 2018-01-31 Impact factor: 4.290

3. Biomarkers and clinical staging in psychiatry.

Authors: Patrick McGorry; Matcheri Keshavan; Sherilyn Goldstone; Paul Amminger; Kelly Allott; Michael Berk; Suzie Lavoie; Christos Pantelis; Alison Yung; Stephen Wood; Ian Hickie
Journal: World Psychiatry Date: 2014-10 Impact factor: 49.548

Review 4. Focus on fatty acids in the neurometabolic pathophysiology of psychiatric disorders.

Authors: R J T Mocking; J Assies; H G Ruhé; A H Schene
Journal: J Inherit Metab Dis Date: 2018-03-09 Impact factor: 4.982

Review 5. Psychopharmacological treatment of neurocognitive deficits in people with schizophrenia: a review of old and new targets.

Authors: Anthony O Ahmed; Ishrat A Bhat
Journal: CNS Drugs Date: 2014-04 Impact factor: 5.749

6. Omega-3 fatty acid supplementation changes intracellular phospholipase A2 activity and membrane fatty acid profiles in individuals at ultra-high risk for psychosis.

Authors: S Smesny; B Milleit; U-C Hipler; C Milleit; M R Schäfer; C M Klier; M Holub; I Holzer; G E Berger; M Otto; I Nenadic; M Berk; P D McGorry; H Sauer; G P Amminger
Journal: Mol Psychiatry Date: 2013-03-12 Impact factor: 15.992

Decreased nervonic acid levels in erythrocyte membranes predict psychosis in help-seeking ultra-high-risk individuals.

Review 1. New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates--Nrf2 activators and GSK-3 inhibitors.

2. Impact of hydroxyurea therapy on serum fatty acids of β-thalassemia patients.

3. Biomarkers and clinical staging in psychiatry.

Review 4. Focus on fatty acids in the neurometabolic pathophysiology of psychiatric disorders.

Review 5. Psychopharmacological treatment of neurocognitive deficits in people with schizophrenia: a review of old and new targets.

6. Omega-3 fatty acid supplementation changes intracellular phospholipase A2 activity and membrane fatty acid profiles in individuals at ultra-high risk for psychosis.

7. Role of Long-Chain Omega-3 Fatty Acids in Psychiatric Practice.

8. Polyunsaturated fatty acid concentration predicts myelin integrity in early-phase psychosis.

Review 9. Perspectives of nervonic acid production by Yarrowia lipolytica.

10. Nervonic acid amends motor disorder in a mouse model of Parkinson's disease.